A Day Up For Translate Bio, Inc.
Fri, Feb 23, 2024 at 07:06 PM
Translate Bio, Inc. (TBIO:NASDAQ) shot up at $0.78, representing a gain of 72.3%. On Fri, Feb 23, 2024, TBIO:NASDAQ hit a New 2-Week High of $0.78. From Fri, Feb 09, 2024, the stock recorded 55.56% Up Days and 40.00% Green Days
About Translate Bio, Inc. (TBIO:NASDAQ)
Translate Bio Inc is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, for the treatment of cystic fibrosis (CF) and MRT5201, for the treatment of ornithine transcarbamylase (OTC) deficiency.
Top 10 Gainers:
- Ocean Biomedical Inc Com (OCEA:NASDAQ), 185.77%
- Vinco Ventures Inc. (BBIG:NASDAQ), 122.22%
- Translate Bio, Inc. (TBIO:NASDAQ), 72.34%
- AXT, Inc. (AXTI:NASDAQ), 69.3%
- Maravai LifeSciences Holdings Inc. (MRVI:NASDAQ), 63.6%
- Alternus Clean Energ Inc Cl A Com (ALCE:NASDAQ), 43.71%
- Gyre Therapeutics Inc Com (GYRE:NASDAQ), 37.69%
- EzFill Holdings Inc. (EZFL:NASDAQ), 37.6%
- Unusual Machines Inc. (UMAC:NYSEMKT), 36.35%
- Sleep Number Corporation (SNBR:NASDAQ), 33.03%